The objective ofthe newly-formed Joslin Advanced Genomics and Genetics Core (AGGC) is to provide support to Joslin and external investigators for the study of genome-based mechanisms of disease, by providing equipment, expertise, and services in nucleic acid analysis that would be too specialized or costly for individual laboratories to perform independently. The AGGC originates from the merging of the Joslin Genomics and Genetics Cores in response to the evolving scientific and technological landscape based on (1) the recognition that gene expression changes are mostly responsible for genetic predisposition to complex disorders and (2) the advent of new sequencing technologies providing a unified framework for DNA and RNA studies. The new Core will continue to provide the services previously offered by the two parent Cores, namely DNA extraction from blood, access to DNA collections from the Core's repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR. However, its defining objective will be to serve as an interface between Joslin investigators and next-generation sequencing by providing assistance with the complex protocols that must be accomplished in order to generate ready-to-sequence samples and which are often a barrier to sequencing approaches. Specifically, Core personnel will prepare sequencing libraries on behalf of Joslin investigators, will provide a next-generation sequencing service for projects requiring relatively low output, will facilitate investigators'access to external high-output next-generation sequencing platforms for larger projects, and will provide study design and analytical assistance in collaboration with the Boston University- Joslin Regional Computational (BUJRC) Core. Availability of these novel services will facilitate the ongoing transition of Joslin investigators to next-generation genomic methodologies, enhancing their productivity and increasing the cost-effectiveness of their research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK036836-26A1
Application #
8447674
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O2))
Project Start
Project End
Budget Start
2012-09-14
Budget End
2013-08-31
Support Year
26
Fiscal Year
2012
Total Cost
$259,822
Indirect Cost
$102,275
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Ussar, Siegfried; Haering, Max-Felix; Fujisaka, Shiho et al. (2017) Regulation of Glucose Uptake and Enteroendocrine Function by the Intestinal Epithelial Insulin Receptor. Diabetes 66:886-896
Harrington, Kara R; Boyle, Claire T; Miller, Kellee M et al. (2017) Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes. J Diabetes Sci Technol 11:980-987
Thelin, Martin A; Kissler, Stephan; Vigneault, Frederic et al. (2017) In Vivo Enrichment of Diabetogenic T Cells. Diabetes 66:2220-2229
Lindsay, Robert S; Loeken, Mary R (2017) Metformin use in pregnancy: promises and uncertainties. Diabetologia 60:1612-1619
Mehta, Sanjeev N; Andersen, Henrik Ullits; Abrahamson, Martin J et al. (2017) Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes. J Diabetes Sci Technol 11:83-86
Chadwick, Jennifer Q; Van Buren, Dorothy J; Morales, Elisa et al. (2017) Structure to utilize interventionists' implementation experiences of a family-based behavioral weight management program to enhance the dissemination of the standardized intervention: The TODAY study. Clin Trials 14:406-412
Salastekar, Ninad; Desai, Tanvi; Hauser, Thomas et al. (2017) Salsalate improves glycaemia in overweight persons with diabetes risk factors of stable statin-treated cardiovascular disease: A 30-month randomized placebo-controlled trial. Diabetes Obes Metab 19:1458-1462
Hou, Yanyan; Kitaguchi, Tetsuya; Kriszt, Rókus et al. (2017) Ca2+-associated triphasic pH changes in mitochondria during brown adipocyte activation. Mol Metab 6:797-808
Forlenza, Gregory P; Argento, Nicholas B; Laffel, Lori M (2017) Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use. Diabetes Technol Ther 19:S13-S20
Simão, Fabrício; Ustunkaya, Tuna; Clermont, Allen C et al. (2017) Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke. Blood 129:2280-2290

Showing the most recent 10 out of 1033 publications